Final results of the phase II study of rabbit anti-thymocyte globulin, ciclosporin, methylprednisone, and granulocyte colony-stimulating factor in patients with aplastic anaemia and myelodysplastic syndrome

British Journal of Haematology

Volumn 157, Issue 3, 2012, Pages 312-320

  Kadia, Tapan M ^a   Borthakur, Gautam ^a   Garcia Manero, Guillermo ^a   Faderl, Stefan ^a   Jabbour, Elias ^a   Estrov, Zeev ^a   York, Sergerrne ^a   Huang, Xuelin ^a   Pierce, Sherry ^a   Brandt, Mark ^a   Koller, Charles ^a   Kantarjian, Hagop M ^a   Ravandi, Farhad ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Hypoplastic; Immunotherapy; Thymoglobulin

Indexed keywords

CYCLOSPORIN; HEMOGLOBIN; HLA DR15 ANTIGEN; MEPREDNISONE; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THYMOCYTE ANTIBODY;

ABDOMINAL PAIN; ADULT; AGE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALBUMIN BLOOD LEVEL; ANEMIA; APLASTIC ANEMIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACTEREMIA; BILIRUBIN BLOOD LEVEL; BLOOD CELL COUNT; CHILL; CLINICAL ARTICLE; CONSTIPATION; COUGHING; CREATININE BLOOD LEVEL; CYTOGENETICS; DIARRHEA; DIZZINESS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; DRUG SAFETY; DRUG TOLERABILITY; DYSPHAGIA; DYSPNEA; EDEMA; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; FEVER; HEADACHE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERTENSION; INFECTION; INSOMNIA; LEUKOCYTOSIS; MAGNESIUM BLOOD LEVEL; MALE; MORTALITY; MUSCULOSKELETAL PAIN; MYELODYSPLASTIC SYNDROME; NAUSEA AND VOMITING; NEUTROPENIA; NEUTROPHIL COUNT; OPEN STUDY; OVERALL SURVIVAL; PHASE 2 CLINICAL TRIAL; PNEUMONIA; POTASSIUM BLOOD LEVEL; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RASH; SEX RATIO; SIDE EFFECT; SODIUM BLOOD LEVEL; THORAX PAIN; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT OUTCOME; TREATMENT RESPONSE; URIC ACID BLOOD LEVEL; URINARY TRACT INFECTION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANEMIA, APLASTIC; ANTILYMPHOCYTE SERUM; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MYELODYSPLASTIC SYNDROMES; SURVIVAL ANALYSIS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84859508819     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2012.09064.x     Document Type: Article

References (38)

1. Afable, M.G., Shaik, M., Sugimoto, Y., Elson, P., Clemente, M.J., Makishima, H., Sekeres, M.A., Lichtin, A., Advani, A., Kalaycio, M., Tiu, R.V., O'Keefe, C. & Maciejewski, J. (2011) Efficacy of rabbit antithymocyte globulin in severe aplastic anemia. Haematologica, 96, 1269-1275.
2. Asano, Y., Maeda, M., Uchida, N., Yokoyama, T., Osaki, K., Shimoda, K., Gondo, H., Okamura, T., Okamura, S. & Niho, Y. (2001) Immunosuppressive therapy for patients with refractory anemia. Annals of Hematology, 80, 634-638.
3. Atta, E.H., Dias, D.S., Marra, V.L. & de Azevedo, A.M. (2010) Comparison between horse and rabbit antithymocyte globulin as first-line treatment for patients with severe aplastic anemia: a single-center retrospective study. Annals of Hematology, 89, 851-859.
4. Bacigalupo, A., Broccia, G., Corda, G., Arcese, W., Carotenuto, M., Gallamini, A., Locatelli, F., Mori, P.G., Saracco, P., Todeschini, G., Coser, P., Iacopino, P., van Lint, M.T. & Gluckman, E. (1995) Antilymphocyte globulin, cyclosporin, and granulocyte colony-stimulating factor in patients with acquired severe aplastic anemia (SAA): a pilot study of the EBMT SAA Working Party. Blood, 85, 1348-1353.
5. Champlin, R., Ho, W. & Gale, R.P. (1983) Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial. New England Journal of Medicine, 308, 113-118.
6. Cheson, B.D., Greenberg, P.L., Bennett, J.M., Lowenberg, B., Wijermans, P.W., Nimer, S.D., Pinto, A., Beran, M., de Witte, T.M., Stone, R.M., Mittelman, M., Sanz, G.F., Gore, S.D., Schiffer, C.A. & Kantarjian, H. (2006) Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia. Blood, 108, 419-425.
7. Di Bona, E., Rodeghiero, F., Bruno, B., Gabbas, A., Foa, P., Locasciulli, A., Rosanelli, C., Camba, L., Saracco, P., Lippi, A., Iori, A.P., Porta, F., De Rossi, G., Comotti, B., Iacopino, P., Dufour, C. & Bacigalupo, A. (1999) Rabbit antithymocyte globulin (r-ATG) plus cyclosporine and granulocyte colony stimulating factor is an effective treatment for aplastic anaemia patients unresponsive to a first course of intensive immunosuppressive therapy. Gruppo Italiano Trapianto di Midollo Osseo (GITMO). British Journal of Haematology, 107, 330-334.
8. Dixit, A., Chatterjee, T., Mishra, P., Choudhary, D.R., Mahapatra, M., Saxena, R. & Choudhry, V.P. (2005) Cyclosporin A in myelodysplastic syndrome: a preliminary report. Annals of Hematology, 84, 565-568.
9. Epling-Burnette, P.K., Painter, J.S., Rollison, D.E., Ku, E., Vendron, D., Widen, R., Boulware, D., Zou, J.X., Bai, F. & List, A.F. (2007) Prevalence and clinical association of clonal T-cell expansions in Myelodysplastic Syndrome. Leukemia, 21, 659-667.
10. Frickhofen, N., Kaltwasser, J.P., Schrezenmeier, H., Raghavachar, A., Vogt, H.G., Herrmann, F., Freund, M., Meusers, P., Salama, A. & Heimpel, H. (1991) Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. New England Journal of Medicine, 324, 1297-1304.
11. Garg, R., Faderl, S., Garcia-Manero, G., Cortes, J., Koller, C., Huang, X., York, S., Pierce, S., Brandt, M., Beran, M., Borthakur, G., Kantarjian, H. & Ravandi, F. (2009) Phase II study of rabbit anti-thymocyte globulin, cyclosporine and granulocyte colony-stimulating factor in patients with aplastic anemia and myelodysplastic syndrome. Leukemia, 23, 1297-1302.
12. Jonasova, A., Neuwirtova, R., Cermak, J., Vozobulova, V., Mocikova, K., Siskova, M. & Hochova, I. (1998) Cyclosporin A therapy in hypoplastic MDS patients and certain refractory anaemias without hypoplastic bone marrow. British Journal Haematology, 100, 304-309.
13. Kook, H., Zeng, W., Guibin, C., Kirby, M., Young, N.S. & Maciejewski, J.P. (2001) Increased cytotoxic T cells with effector phenotype in aplastic anemia and myelodysplasia. Experimental Hematology, 29, 1270-1277.
14. Maciejewski, J.P., Risitano, A., Kook, H., Zeng, W., Chen, G. & Young, N.S. (2002) Immune pathophysiology of aplastic anemia. International Journal of Hematology, 76(Suppl. 1), 207-214.
15. Mathe, G., Amiel, J.L., Schwarzenberg, L., Choay, J., Trolard, P., Schneider, M., Hayat, M., Schlumberger, J.R. & Jasmin, C. (1970) Bone marrow graft in man after conditioning by antilymphocytic serum. British Medical Journal, 2, 131-136.
16. Molldrem, J.J., Leifer, E., Bahceci, E., Saunthararajah, Y., Rivera, M., Dunbar, C., Liu, J., Nakamura, R., Young, N.S. & Barrett, A.J. (2002) Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes. Annals of Internal Medicine, 137, 156-163.
17. Rosenfeld, S.J., Kimball, J., Vining, D. & Young, N.S. (1995) Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood, 85, 3058-3065.
18. Rosenfeld, S., Follmann, D., Nunez, O. & Young, N.S. (2003) Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA, 289, 1130-1135.
19. Saunthararajah, Y., Nakamura, R., Wesley, R., Wang, Q.J. & Barrett, A.J. (2003) A simple method to predict response to immunosuppressive therapy in patients with myelodysplastic syndrome. Blood, 102, 3025-3027.
20. Scheinberg, P., Nunez, O. & Young, N.S. (2006a) Retreatment with rabbit anti-thymocyte globulin and ciclosporin for patients with relapsed or refractory severe aplastic anaemia. British Journal of Haematology, 133, 622-627.
21. Scheinberg, P., Nunez, O., Wu, C. & Young, N.S. (2006b) Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil. British Journal of Haematology, 133, 606-611.
22. Scheinberg, P., Fischer, S.H., Li, L., Nunez, O., Wu, C.O., Sloand, E.M., Cohen, J.I., Young, N.S. & John Barrett, A. (2007) Distinct EBV and CMV reactivation patterns following antibody-based immunosuppressive regimens in patients with severe aplastic anemia. Blood, 109, 3219-3224.
23. Scheinberg, P., Wu, C.O., Nunez, O., Boss, C., Sloand, E.M. & Young, N.S. (2009) Treatment of severe aplastic anemia with a combination of horse antithymocyte globulin and cyclosporine, with or without sirolimus: a prospective randomized study. Haematologica, 94, 348-354.
24. Scheinberg, P., Nunez, O., Weinstein, B., Biancotto, A., Wu, C.O. & Young, N.S. (2011) Horse versus rabbit antithymocyte globulin in acquired aplastic anemia. New England Journal of Medicine, 365, 430-438.
25. Schrezenmeier, H., Marin, P., Raghavachar, A., McCann, S., Hows, J., Gluckman, E., Nissen, C., van't Veer-Korthof, E.T., Ljungman, P., Hinterberger, W., van Lint, M.T., Frickhofen, N. & Bacigalupo, A. (1993) Relapse of aplastic anaemia after immunosuppressive treatment: a report from the European Bone Marrow Transplantation Group SAA Working Party. British Journal of Haematology, 85, 371-377.
26. Shimamoto, T., Iguchi, T., Ando, K., Katagiri, T., Tauchi, T., Ito, Y., Yaguchi, M., Miyazawa, K., Kimura, Y., Masuda, M., Mizoguchi, H. & Ohyashiki, K. (2001) Successful treatment with cyclosporin A for myelodysplastic syndrome with erythroid hypoplasia associated with T-cell receptor gene rearrangements. British Journal of Haematology, 114, 358-361.
27. Shimamoto, T., Tohyama, K., Okamoto, T., Uchiyama, T., Mori, H., Tomonaga, M., Asano, Y., Niho, Y., Teramura, M., Mizoguchi, H., Omine, M. & Ohyashiki, K. (2003) Cyclosporin A therapy for patients with myelodysplastic syndrome: multicenter pilot studies in Japan. Leukemia Research, 27, 783-788.
28. Sloand, E.M., Olnes, M.J., Shenoy, A., Weinstein, B., Boss, C., Loeliger, K., Wu, C.O., More, K., Barrett, A.J., Scheinberg, P. & Young, N.S. (2010) Alemtuzumab treatment of intermediate-1 myelodysplasia patients is associated with sustained improvement in blood counts and cytogenetic remissions. Journal of Clinical Oncology, 28, 5166-5173.
29. Speck, B., Gluckman, E., Haak, H.L. & van Rood, J.J. (1977) Treatment of aplastic anaemia by antilymphocyte globulin with and without allogeneic bone-marrow infusions. Lancet, 2, 1145-1148.
30. Stadler, M., Germing, U., Kliche, K.O., Josten, K.M., Kuse, R., Hofmann, W.K., Schrezenmeier, H., Novotny, J., Anders, O., Eimermacher, H., Verbeek, W., Kreipe, H.H., Heimpel, H., Aul, C. & Ganser, A. (2004) A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes. Leukemia, 18, 460-465.
31. Thall, P.F. & Sung, H.G. (1998) Some extensions and applications of a Bayesian strategy for monitoring multiple outcomes in clinical trials. Statistics in Medicine, 17, 1563-1580.
32. Thall, P.F., Simon, R.M. & Estey, E.H. (1995) Bayesian sequential monitoring designs for single-arm clinical trials with multiple outcomes. Statistics in Medicine, 14, 357-379.
33. Thall, P.F., Simon, R.M. & Estey, E.H. (1996) New statistical strategy for monitoring safety and efficacy in single-arm clinical trials. Journal of Clinical Oncology, 14, 296-303.
34. Yazji, S., Giles, F.J., Tsimberidou, A.M., Estey, E.H., Kantarjian, H.M., O'Brien, S.A. & Kurzrock, R. (2003) Antithymocyte globulin (ATG)-based therapy in patients with myelodysplastic syndromes. Leukemia, 17, 2101-2106.
35. Young, N.S. (2002) Acquired aplastic anemia. Annals of Internal Medicine, 136, 534-546.
36. Young, N.S. & Maciejewski, J. (1997) The pathophysiology of acquired aplastic anemia. New England Journal of Medicine, 336, 1365-1372.
37. Young, N., Griffith, P., Brittain, E., Elfenbein, G., Gardner, F., Huang, A., Harmon, D., Hewlett, J., Fay, J., Mangan, K., Morrison, F., Sensenbrenner, L., Shadduck, R., Wang, W., Zaroulis, C. & Zuckerman, K. (1988) A multicenter trial of antithymocyte globulin in aplastic anemia and related diseases. Blood, 72, 1861-1869.
38. Zheng, Y., Liu, Y. & Chu, Y. (2006) Immunosuppressive therapy for acquired severe aplastic anemia (SAA): a prospective comparison of four different regimens. Experimental Hematology, 34, 826-831.